Jones S - Search Results

1

Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas.

Aghajanian C, Burris HA 3rd, Jones S, Spriggs DR, Cohen MB, Peck R, Sabbatini P, Hensley ML, Greco FA, Dupont J, O'Connor OA. Aghajanian C, et al. Among authors: jones s. J Clin Oncol. 2007 Mar 20;25(9):1082-8. doi: 10.1200/JCO.2006.08.7304. Epub 2007 Jan 29. J Clin Oncol. 2007. PMID: 17261851 Clinical Trial.

2

A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation.

Rinaldi DA, Kuhn JG, Burris HA, Dorr FA, Rodriguez G, Eckhardt SG, Jones S, Woodworth JR, Baker S, Langley C, Mascorro D, Abrahams T, Von Hoff DD. Rinaldi DA, et al. Among authors: jones s. Cancer Chemother Pharmacol. 1999;44(5):372-80. doi: 10.1007/s002800050992. Cancer Chemother Pharmacol. 1999. PMID: 10501910 Clinical Trial.

3

Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies.

Jones S, Hainsworth J, Burris HA 3rd, Thompson D, Raefsky E, Johnson V, Calvert S, Bulanhagui C, Lebwohl D, Greco FA. Jones S, et al. Invest New Drugs. 2002 Feb;20(1):55-61. doi: 10.1023/a:1014473930546. Invest New Drugs. 2002. PMID: 12008664 Clinical Trial.

4

A phase I trial of weekly paclitaxel plus prolonged oral eniluracil/5-fluorouracil in patients with refractory malignancies.

Jones SF, Greco FA, Hainsworth JD, Patton JW, Barton JH, Willcutt NT, Baker MN, McGuirt PV, Levin J, Burris HA 3rd. Jones SF, et al. Oncologist. 2002;7(5):444-50. doi: 10.1634/theoncologist.7-5-444. Oncologist. 2002. PMID: 12401907 Free article. Clinical Trial.

5

Phase I. Trial of irinotecan plus carboplatin in two dose schedules.

Jones SF, Burris HA 3rd, Hainsworth JD, Yardley DA, Raefsky EA, Miranda FT, Kuzur ME, Willcutt NT, White MB, Greco FA. Jones SF, et al. Oncology (Williston Park). 2003 May;17(5 Suppl 5):36-40. Oncology (Williston Park). 2003. PMID: 12800605 Review.

6

Phase I. Trial of irinotecan and temozolomide in patients with solid tumors.

Jones SF, Gian VG, Greco FA, Miranda FT, Shipley DL, Thompson DS, Hainsworth JD, Toomey MA, Willcutt NT, Burris HA 3rd. Jones SF, et al. Oncology (Williston Park). 2003 May;17(5 Suppl 5):41-5. Oncology (Williston Park). 2003. PMID: 12800606 Clinical Trial.

7

Gefitinib in the treatment of advanced, refractory non-small-cell lung cancer: results in 124 patients.

Hainsworth JD, Mainwaring MG, Thomas M, Porter LL 3rd, Gian VG, Jones SF, Greco FA. Hainsworth JD, et al. Clin Lung Cancer. 2003 May;4(6):347-55. doi: 10.3816/clc.2003.n.014. Clin Lung Cancer. 2003. PMID: 14599303

8

Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer.

Burris H 3rd, Yardley D, Jones S, Houston G, Broome C, Thompson D, Greco FA, White M, Hainsworth J. Burris H 3rd, et al. Among authors: jones s. J Clin Oncol. 2004 May 1;22(9):1621-9. doi: 10.1200/JCO.2004.08.065. J Clin Oncol. 2004. PMID: 15117984 Clinical Trial.

9

A phase I/II study of exisulind in combination with docetaxel/carboplatin in patients with metastatic non-small-cell lung cancer.

Jones SF, Kuhn JG, Greco FA, Raefsky EL, Hainsworth JD, Dickson NR, Thompson DS, Willcutt NT, White MB, Burris HA 3rd. Jones SF, et al. Clin Lung Cancer. 2005 May;6(6):361-6. doi: 10.3816/clc.2005.n.016. Clin Lung Cancer. 2005. PMID: 15943897 Clinical Trial.

10

Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas.

Burris HA 3rd, Hurwitz HI, Dees EC, Dowlati A, Blackwell KL, O'Neil B, Marcom PK, Ellis MJ, Overmoyer B, Jones SF, Harris JL, Smith DA, Koch KM, Stead A, Mangum S, Spector NL. Burris HA 3rd, et al. Among authors: jones sf. J Clin Oncol. 2005 Aug 10;23(23):5305-13. doi: 10.1200/JCO.2005.16.584. Epub 2005 Jun 13. J Clin Oncol. 2005. PMID: 15955900 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,582 results

Search Page